Cited by 43Wound Healing and TreatmentsRheumatoid Arthritis Research and TherapiesPhytochemistry and biological activity of medicinal plants

Etanercept decreases tumor necrosis factor‐α activity in chronic wound fluid

Cowin, Allison J., Hatzirodos, Nicholas, Rigden, Justin, Fitridge, Robert, Belford, David A.·2006·Wound Repair and Regeneration

Abstract

High levels of tumor necrosis factor‐α (TNF‐α), a pro‐inflammatory cytokine, are present in the wound fluid of chronic nonhealing wounds. This leads to increased inflammation, cytokine expression, and ultimately results in impaired wound healing and tissue destruction. Etanercept is a recombinant fusion protein that consists of the soluble TNF receptor (p75) linked to the Fc portion of human IgG1. It is an effective inhibitor of TNF‐α and has been shown to provide rapid and sustained improvement in rheumatoid arthritis by acting as a soluble receptor binding TNF‐α and preventing its proinflammatory activities. Therefore, the aim of this study was to determine whether Etanercept could inhibit TNF‐α activity in chronic wound fluid. Wound fluid was collected from the venous leg ulcers of 16 different patients. The effect of Etanercept on TNF‐α activity was evaluated using both a TNF‐α bioassay and an enzyme‐linked immunoassay. Etanercept was found to reduce the cytotoxic effect of chronic wound fluid on L929 fibroblasts by approximately 30% and neutralized TNF‐α binding in the enzyme‐linked immunoassay by up to 80%. Direct application of Etanercept to chronic wounds may therefore reduce the inflammatory activity of TNF‐α, which could reduce the chronicity of venous leg ulcers and thus aid in the healing of these wounds.

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2006.00141.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High levels of TNFα are present in the wound fluid of chronic nonhealing wounds, leading to excessive inflammation ultimately resulting in impaired wound healing and tissue destruction.

    “High levels of TNFα are present in the wound fluid of chronic nonhealing wounds, leading to excessive inflammation ultimately resulting in impaired wound healing and tissue destruction.63”

    From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [63]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cowin, A. J., Hatzirodos, N., Rigden, J., Fitridge, R., & Belford, D. A.
Affiliations
  • Women's and Children's Hospital (AU)
  • Queen Elizabeth Hospital (AU)
Corresponding author
Cowin, Allison J.
Venue
Wound Repair and Regeneration
Publisher
Wiley
Published
2006-07
Volume
14
Issue
4
Pages
421-426
ISSN
  • 1067-1927 (ISSN-L)
  • 1524-475X
OpenAlex
W2080890577
Cited by
43
References
22
Citations by year
2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2017: 1 · 2016: 1 · 2015: 11 · 2014: 2 · 2012: 2
FWCI
1.50
Type
journal article
Language
en
Open access
closed
Locations
  • Wound Repair and Regeneration (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and biological activity of medicinal plants
Keywords
etanercept, TNF-α, chronic wounds, wound fluid, venous leg ulcers, anti-TNF therapy, soluble TNF receptors, inflammation, wound healing, L929 fibroblasts, cytotoxicity
MeSH terms
Etanercept, Aged, Aged, 80 and over, Biological Assay, Chronic Disease, Enzyme-Linked Immunosorbent Assay, Fibroblasts, Humans, Immunoglobulin G, Immunologic Factors, Middle Aged, Tumor Necrosis Factor-alpha, Varicose Ulcer, Receptors, Tumor Necrosis Factor, Cell Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review